Filter

Refine by Access

Refine by Date

—
  • Print

Browse

You are looking at 91 - 100 of 2,970 items for

Full access

CLO20-056: Real-Life Experience of Treatment With Anti-Programmed Cell Death-1 (PD-1) or Programmed Death-Ligand 1 (PD-L1) Antibodies in Patients With Non-Small Cells Lung Cancer (NSCLC)

Gianfranco Puppo, Gian Paolo Mattioli, Sara De Magistris, Erilda Kamberi, Maria Serafini, Giordano Riccioni, Yuri Rosati and Francesca Marchesani

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-057: A Meta-Analysis on Gastrointestinal (GI) and Hepatic Toxicities Associated With Upfront Use of Immune Checkpoint Inhibitor and Anti-Angiogenic Tyrosine Kinase Inhibitor Combinations for Advanced Renal Cell Carcinoma

Miguel Angel Quirch, Nusrat Jahan, Meda Srikala, Fred Hardwicke and Lukman Tijani

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-058: Characteristics of Gynecological Anamnesis and its Prognostic Role in Azerbaijani Women With Breast Cancer

Sevinj E. Rahimzade, Jamil A. Aliyev, Elkhan E. Kazimov, Leylakhanum A. Melikova, Konul S. Mardanova, Turkan E. Mansurova and Elchin B. Mansurov

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-059: Comparison of a Single Dose Immediate Instillation of Mitomycin C 20mg Versus 40mg in Prevention of Tumour Recurrence After Resection of Non Muscle Invasive Bladder Cancer

Shree Vishnu Siddarth, Ginil Kumar Pooleri and Georgie Mathew

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-060: Factors Associated with the Uptake of Adjuvant Pertuzumab in Patients with Stage I-III HER2-positive Breast Cancer: The University of Colorado Cancer Center Experience

Ericson Stoen, Jodi Kagihara, Peter Kabos, Christine Fisher and Jennifer R. Diamond

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-061: A Meta-Analysis on the Safety of Panobinostat Compared to Eltozumab and Ixazomib for the Treatment of Multiple Myeloma

Nishanth Thalambedu, Waqas Ullah, Ammar Ashfaq, Yasir Khan, Mishal Shaukat and Qian Zhang

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-062: Comparative Efficacy of Elotozumab With Panobinostat and Ixazomib in Multiple Myeloma; A Meta-Analysis

Nishanth Thalambedu, Waqas Ullah, Ammar Ashfaq, Yasir Khan, Ammar Ashfaq, Qian Zhang and Mishal Shaukat

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-063: Late Dosing of Leuprolide and Testosterone Levels >20NG/DL in Prostate Cancer Patients

Przemyslaw Twardowski, Stuart Atkinson, Deborah M. Boldt-Houle and Raoul S. Concepcion

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-064: A Case Series of Ectopic Cushing Syndrome in Atypical Lung Carcinoid

Neha Verma, Manisha Shah, Luma Ghalib, Lawrence Kirschner, Mayumi Endo and Bhavana Konda

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020
Full access

CLO20-066: Comparative Efficacy, Safety and Acceptability of Single-Agent Poly (ADP-ribose) Polymerase (PARP) Inhibitors in BRCA Mutated HER2-Negative Metastatic or Advanced Breast Cancer: A Network Meta-Analysis

Ju Wang, Ye Zhang, Long Yuan, Lin Ren, Yi Zhang and Xiaowei Qi

Cover Journal of the National Comprehensive Cancer Network

In Journal of the National Comprehensive Cancer Network Volume 18 (2020): Issue 3.5 (Mar 2020): Abstracts from the NCCN 2020 Annual Conference

20 Mar 2020